We are live on ! Find out more
BIOTW

Biotech Acquisition Company Warrant
BIOTW

Delisted

BIOTW was delisted on the 2nd of February, 2023.

Back to rankings

51 hedge funds and large institutions have $3.8M invested in Biotech Acquisition Company Warrant in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% more funds holding

Funds holding: 48 → 51 (+3)

10% less capital invested

Capital invested by funds: $4.21M → $3.8M (-$414K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 5

Holders
51
Holders Change
+3
Holders Change %
+6.25%
% of All Funds
0.88%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
5
Closed
–
Calls
$5.72M
Puts
–
Net Calls
+$5.72M
Net Calls Change
+$4K

Top Buyers

Rank Fund Capital Flow
1
PC
Periscope Capital
Ontario, Canada
+$5.81K
2
PCM
Prelude Capital Management
New York
+$1.09K

Top Sellers

Rank Fund Capital Flow
1
HIM
HGC Investment Management
Ontario, Canada
-$71.4K
2
BFM
Boothbay Fund Management
New York
-$1.46K
3
MC
Meteora Capital
Florida
-$298
4
UBS Group
UBS Group
Switzerland
-$84
5
Citadel Advisors
Citadel Advisors
Florida
-$82
Name Holding Trade Value Shares
Change 		Change in
Stake
CP
26
Centerbridge Partners
New York
$4K – – –
HF
27
HRT Financial
New York
$4K – – –
Walleye Capital
28
Walleye Capital
New York
$4K – – –
CCA
29
Castle Creek Arbitrage
Colorado
$3K – – –
CS
30
Clear Street
New York
$3K – – –
CCM
31
Context Capital Management
California
$3K – – –
Jane Street
32
Jane Street
New York
$3K – – –
WA
33
Whitebox Advisors
Minnesota
$3K – – –
UBS Group
34
UBS Group
Switzerland
$2K -$84 -1,449 -5%
AA
35
AQR Arbitrage
Connecticut
$2K – – –
SSA
36
Schonfeld Strategic Advisors
New York
$2K – – –
State of Wisconsin Investment Board
37
State of Wisconsin Investment Board
Wisconsin
$2K – – –
Walleye Trading
38
Walleye Trading
New York
$2K – – –
WAM
39
Wolverine Asset Management
Illinois
$2K – – –
MC
40
Meteora Capital
Florida
$1K -$298 -5,128 -21%
AA
41
Ancora Advisors
Ohio
$1K – – –
Bank of America
42
Bank of America
North Carolina
$1K – – –
BCM
43
Basso Capital Management
Connecticut
$1K – – –
BCM
44
BCK Capital Management
Connecticut
$1K – – –
CC
45
Centiva Capital
New York
$1K – – –
OAC
46
OMERS Administration Corp
Ontario, Canada
$1K – – –
OCAM
47
Owl Creek Asset Management
New York
$1K – – –
PFM
48
Privium Fund Management
Netherlands
$1K – – –
PCM
49
Prelude Capital Management
New York
$1K +$1.09K +18,731 New
ETH
50
Exos TFP Holdings
New York
– +$6 +100 New
1
2

BIOTW Hedge Fund Activity: Q3 2022 in Review

51 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Biotech Acquisition Company Warrant (BIOTW) for Q3 2022, worth a combined $3.8M — down 9.8% from $4.21M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new BIOTW positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 5 trimmed.

The largest buyer was Periscope Capital, opening a new position worth an estimated $5.81K. The largest seller was HGC Investment Management, cutting an estimated $71.4K.

  • 51 institutional investors held Biotech Acquisition Company Warrant (BIOTW) as of Q3 2022, up from 48 in Q2 2022.
  • Funds reported $3.8M of Biotech Acquisition Company Warrant stock for Q3 2022, down 9.8% quarter-over-quarter.
  • 3 funds opened new Biotech Acquisition Company Warrant positions in Q3 2022 and 0 closed out, a net change of +3 holders.
  • The largest Biotech Acquisition Company Warrant buyer in Q3 2022 was Periscope Capital, an estimated $5.81K added.
  • The largest Biotech Acquisition Company Warrant seller in Q3 2022 was HGC Investment Management, an estimated $71.4K sold.

Based on aggregated 13F filings for Q3 2022.